News


Nature, J Clin Invest, Cell Rep, Nat Chem Biol: our 5 latest publications

Category: Highlighted publications at the CRCM

 

 

 

Immune evasion before tumour invasion in early lung squamous carcinogenesis.

Mascaux C, Angelova M, Vasaturo A, Beane J, Hijazi K, Anthoine G, Buttard B, othe F , Willard-Gallo K, Haller A, Ninane V, Burny A, Sculier JP, Spira A, Galon J

Nature. 2019 Jun 26. doi: 10.1038/s41586-019-1330-0. 

www.ncbi.nlm.nih.gov/pubmed/31243362


Sensitive and easy screening for circulating tumor cells by flow cytometry.

Lopresti A, Malergue F, Bertucci F, Liberatoscioli ML, Garnier S, DaCosta Q, Finetti P, Gilabert M, Raoul JL, Birnbaum D, Acquaviva C, Mamessier E.

JCI Insight. 2019 Jun 13;5. pii: 128180. doi: 10.1172/jci.insight.128180.

www.ncbi.nlm.nih.gov/pubmed/31194699 



Genomic characterization of metastatic breast cancers.

Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Tran Dien A, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Tabernero J, Chia S, Martinalbo J, Perez-Moreno P, Dogan S, Verret B, Chaffanet M, Bacelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron D, Le Tourneau C & André F.

Nature 2019, doi.org/10.1038/s41586-019-1056-z  



Ligand-based design of a potent inhibitor of NUPR1 exerting anticancer activity via necroptosis

Santofimia-Catano P, Xia Y, Lan W, Zhou Z, Huang C, Peng L, Soubeyran P, Velazquez-Campoy A, Abian O, Rizzuti B, Neira JL, Iovanna JL.

Journal of Clinical Investigations 2019, doi.org/10.1172/JCI127223

www.ncbi.nlm.nih.gov/pubmed/30920390  


Nidogen-1 contributes to the interaction network involved in pro B cell retention in the perisinusoidal hematopoietic stem cell niche.

Balzano M, De Grandis M, Vu-Manh T-P, Chasson L, Bardin F, Farina A, Sergé A, Bidaut G, Charbord P, Herault, Bailly A-L, Michaud Cartier A, Boned A, Dalod M, Duprez E, Genever P, Coles M, Bajenoff M, Xerri L, Aurrand-Lions M, Schiff C & Mancini S

Cell Reports 2019 doi 10.1016/j.celrep.2019.02.065

www.ncbi.nlm.nih.gov/pubmed/



PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling.

Nawrotek A, Benabdi S, Niyomchon S, Kryszke MH, Ginestier C, Cañeque T, Tepshi L, Mariani A, St Onge RP, Giaever G, Nislow C, Charafe-Jauffret E, Rodriguez R, Zeghouf M, Cherfils J.

Nat Chem Biol. 2019 Feb 11. doi: 10.1038/s41589-019-0228-3. 

www.nature.com/articles/s41589-019-0228-3